ArticleArchives of osteoporosis2021

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan.

Ben Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.